Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe versus simvastatin versus combination therapy on LDL subfractions in type 2 diabetes
2006-005906-30Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ezetimibe and simvastatin in type 2 diabetes mellitus (T2DM) and dyslipidemia (3 arms), sponsored by Universitätsklinikum Freiburg. Started Apr 2007; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on 2006-005906-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005906-30.